Syntheses of Norstatine, Its Analogs, and Dipeptide Isosteres by Means of β-Lactam Synthon Method
Part of the
Methods in Molecular Medicine™
book series (MIMM, volume 23)
Nonprotein amino acids are the amino acids that are not found in protein-main chains and mostly originate in plants, microorganisms, and marine products. Certain nonprotein amino acids exhibit biological activities by themselves, and many of them are important constituents of biologically active compounds of medicinal interest. For this reason, in addition to the naturally occurring nonprotein amino acids, synthetic nonprotein amino acids have been studied extensively, especially in connection with the design and synthesis of various enzyme inhibitors. Indeed, statine, norstatine, and their analogs, as well as a variety of dipeptide isosteres, have been developed and incorporated in various inhibitors of enzymes such as renin and HIV-1 protease with great success (1). These amino acid residues and their isosteres provide effective transition-state mimics of the substrates for peptidases that bind to these enzymes tightly and inhibit their actions. Although a number of methods has been reported for the synthesis of statine and its analogs (2, 3, 4, 5, 6, 7), to date, only a few synthetic methods are available for norstatine and its analogs (8, 9, 10, 11, 12). The β-lactam synthon method developed by these laboratories (13, 14, 15, 16, 17) can be effectively applied to the asymmetric synthesis of norstatine and its analogs, as well as various dipeptide isosteres. In this chapter, the preparation of 3-siloxy-β-lactams will be described first, followed by those of norstatine and its analogs, as well as dihydroxyethylene, hydroxyethylamine and other dipeptide isosteres.
KeywordsCerium Ammonium Nitrate Nonprotein Amino Acid Methyl Ester Hydrochloride Saturated Aqueous NaHCO3 Pyridinium Chlorochromate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Huff, J. R. (1991) HIV Protease: A novel chemotherapeutic target for AIDS. J. Med. Chem.
, 2305–2314.CrossRefGoogle Scholar
Koot, W.-J., Van Ginkel, R., Kranenburg, M., Hiemstra, H., Louwrier, S., Moolenaar, M. J., and Speckamps, W. N. (1991) Synthesis of statine from (s)-malic acid; stereocontrol via radical cyclization. Tetrahedron Lett.
, 401–404.CrossRefGoogle Scholar
Nebois, P. and Greene, A. E. (1996) Novel enantioselective approach to γ-lactams from chiral enol ethers: Synthesis of (−)-statine. J. Org. Chem.
, 5210–5211.CrossRefGoogle Scholar
Takemoto, Y., Matsumoto, T., Ito, Y., and Terashima, S. (1990) An expeditious synthesis of (3S
)-statine and (3S,4S)-cyclohexylstatine. Tetrahedron Lett.
, 217–218.CrossRefGoogle Scholar
Kunieda, T., Ishizuka, T., Higuchi, T., and Hirobe, M. (1988) Versatile chiral synthons for vic-amino alcohols—Facile synthesis of (2S
)-3-hydroxyglutamic acid and (+) statine. J. Org. Chem.
, 3381–3383.CrossRefGoogle Scholar
Jouin, P., and Castro, B. (1987) Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid. J. Chem. Soc. Perkin Trans.
, 1177.CrossRefGoogle Scholar
Yanagisawa, H., Kanazaki, T., and Nishi, T. (1989) Synthesis of Statine and Its Analogues. Chem. Lett.
Pasto, M, Castejon, P., Moyano, A., Pericas, M. A., and Riera, A. (1996) A catalytic asymmetric synthesis of cyclohexylnorstatine. J. Org. Synth.
, 6033–6037.Google Scholar
Matsumoto, T., Kobayashi, Y., Takemoto, Y., Ito, Y., Kamijo, T., Harada, H., and Terashima, S. (1990) A stereoselective synthesis of cyclohexylnorstatine, the key component of a Renin Inhibitor. Tetrahedron Lett.
, 4175–4176.CrossRefGoogle Scholar
Kobayashi, Y., Takemoto, Y., Ito, Y., and Terashima, S. (1990) A Novel Synthesis of (2R
)-3-dmino-2-hydrocarboxylic acid derivatives, the key components of a renin inhibitor and bestatin, from methyl (R
)-mandelate. Tetrahedron Lett.
, 3031–3034.CrossRefGoogle Scholar
Ito, Y., Kamijo, T., Harada, H., and Terashima, S. (1990) A novel synthesis of xyclohexylnorstatine isoprpylester, the C-terminal component of a renin inhibitor. Heterocycles
, 299–302.CrossRefGoogle Scholar
Iizuka, K., Kamijo, T., Harada, H., Akahane, K., Kubota, T., Uneyama, H., Ishida, T., and Kiso, Y. (1990) Orally potent human renin inhibitor derived from angiotensinogen transition state: design, synthesis and mode of interaction. J. Med. Chem.
, 2707–2714.CrossRefGoogle Scholar
Ojima, I. (1995) Recent advances in β-lactam synthon method. Ace. Chem. Res.
, 383–389.CrossRefGoogle Scholar
Ojima, I. (1995) Advances in Asymmetric Syntheses by Means of the β-Lactam Synthon method
, vol. 1. JAI, New York, pp. 95–146.Google Scholar
Ojima, I. (1992) β-Lactam synthon method—enantiomerically pure β-lactams as Synthetic intermediates, in The Organic Chemistry of β-Lactam Antiobiotics
(Georg, G. I., ed.), VCH, New York, pp. 197–255.Google Scholar
Ojima, I., Habus, I., Zhao, M., Zucco, M, Park, Y. H., Sun, C.-M., and Brigaud, T. (1992) New and efficient approaches to the semisynthesis of taxol and its C-13 side chain analogs by means of β-lactam synthon method. Tetrahedron
, 6985–7012.CrossRefGoogle Scholar
Ojima, I., Habus, I., Zhao, M., Georg, G. I., and Jayasinghe, R. (1991) Efficient and practical asymmetric synthesis of the taxol C-13 side chain, N
)-3-phenylisoserine, and its analogs via chiral 3-hydroxyl-4-aryl-β-lactams through chiral ester enolate—imine cyclocondensation. J. Org. Chem.
, 1681–1684.CrossRefGoogle Scholar
Ojima, I., Park, Y. H., Sun, C. M, Brigaud, T., and Zhao, M. (1992) New and efficient routes to norstatine and its analogs with high enantiomeric purity by β-lactam synthon method. Tetrahedron Lett.
, 5737–5740.CrossRefGoogle Scholar
Whitesell, J. K. and Lawrence, R. M. (1986) Practical enzymatic resolution of chiral auxiliaries—enantiomerically pure trans
-2-phenylcyclohexanol and trans
, 318.Google Scholar
Kukla, M. J., and Fortunato, J. M. (1984) Oxygenated analogues of 4-[(1H-imidazol-4-yl)methyl]-2,5-dimethyloxazole. J. Org. Chem.
, 5003–5006.CrossRefGoogle Scholar
Corey, E. J. and Schmidt, G. (1979) Useful procedures for the oxidation of alcohols involving pyridinium dichromate in aprotic media. Tetrahedron Lett.
, 399.CrossRefGoogle Scholar
Ojima, I., Sun, C. M, and Park, Y. H. (1994) New and efficient coupling method for the synthesis of peptides bearing norstatine residue and their analogs. J. Org. Chem.
, 1249–1250.CrossRefGoogle Scholar
Ojima, I., Ng, E. W., and Sun, C. M. (1995) Novel route to hydroxy(keto)ethylene dipeptide isosteres through the reaction of N
Boc-β-lactams with enolates. Tetrahedron Lett.
, 4547–4550.CrossRefGoogle Scholar
Ng, E. W. (1996) Asymmetric Synthesis of Isoserine-Containing Dipeptides Isosteres via the β-Lactam Synthon Method. PhD, Dissertation, State University of New York at Stony Brook.Google Scholar
Thaisrivongs, S., Pals, D. T., Kroll, L. T., Turner, S. R., and Han, F.-S. (1987) Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel (2R
)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid. J. Med. Chem.
, 976–982.CrossRefGoogle Scholar
Wang, H., Wang, T., Delaloge, F., and Ojima, I. (1997). Unpublished results.Google Scholar
Tsuji, J. (1984) Synthetic applications of the palladium-catalyzed oxidation of olefins to ketones. Synthesis
Luly, J. R., Dellaria, J. F., Planner, J. J., Soderquist, J. L., and Yi, N. (1987) A synthesis of protected aminoalkyl epoxides from α-amino acids. J. Org. Chem.
, 1487–1492.CrossRefGoogle Scholar
© Humana Press Inc., Totowa, NJ 1999